Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.

Christine BernsmeierAnna CavazzaEvangelia M FatourouEleni TheocharidouAbisoye AkintimehinBenjamin BaumgartnerAmeet DharGeorg AuzingerMark ThurszWilliam BernalJulia A WendonConstantine J KarvellasCharalambos G AntoniadesMark J W McPhail

Published in: Alimentary pharmacology & therapeutics (2020)

Leucocyte ratios are simple and robust biomarkers of outcome in ACLF, which are comparable to CLIF-SOFA score but dependent on leucocyte quantification method. NLR and MLR may be used as screening tools for mortality prediction in patients with acutely deteriorating cirrhosis.

Keyphrases

liver failure
hepatitis b virus
cardiovascular events
coronary artery disease
type diabetes
drug induced
intensive care unit